vimarsana.com

Page 6 - இல் விட்ரோ பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HORIBA acquires MedTest Dx and Pointe Scientific to expand laboratory Chemistry offerings

HORIBA acquires MedTest Dx and Pointe Scientific to expand laboratory Chemistry offerings News provided by Share this article Share this article IRVINE, Calif., Feb. 2, 2021 /PRNewswire/  HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California) announced today that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.). The acquisition will combine the complimentary innovative technology offerings of the HORIBA Medical segment (referred to as HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific s R&D and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD1 testing customers.

In-Vitro Diagnostics (IVD) Industry SWOT Analysis, Size, Share, Price, Trends and Growth Forecast to 2025

In-Vitro Diagnostics (IVD) Industry SWOT Analysis, Size, Share, Price, Trends and Growth Forecast to 2025
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

Global MRD (Minimal Residual Disease) Testing Markets 2020-2025: Opportunities in Potential Long-Term Cost Savings & Technological Evolution of Testing

Share this article Share this article ResearchAndMarkets.com s offering. The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period, 2020-2025. MRD Testing industry to be one of the most rapidly evolving and dynamic markets. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, the increasing consumer awareness for tailored therapy, the increasing research funding from the National Cancer Institute, and the increasing disposable income in emerging economies. The market is favored by the developments in the field of MRD testing solutions for hematologic malignancies and solid tumors. Currently, the MRD testing industry is witnessing an upsurge due to the rising incidence of hematologic malignancies, resulting in the high demand for sensitive testing solutions. Additionally, the high adoption of MRD tests among patients and the growing awareness among physicians regarding MRD testing are some o

Exclusive Report on Medical Microfluidic Devices Market 2014-2027

Exclusive Report on Medical Microfluidic Devices Market 2014-2027
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.